コンテンツへスキップ
Merck
  • The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.

Bioorganic & medicinal chemistry (2015-07-29)
David A Perrey, Ann M Decker, Jun-Xu Li, Brian P Gilmour, Brian F Thomas, Danni L Harris, Scott P Runyon, Yanan Zhang
要旨

Selective antagonism of the orexin 1 (OX1) receptor has been proposed as a potential mechanism for treatment of drug addiction. We have previously reported studies on the structure-activity relationships of tetrahydroisoquinoline-based antagonists. In this report, we elucidated the respective role of the 6- and 7-substitutions by preparation of a series of either 6-substituted tetrahydroisoquinolines (with no 7-substituents) or vice versa. We found that 7-substituted tetrahydroisoquinolines showed potent antagonism of OX1, indicating that the 7-position is important for OX1 antagonism (10 c, Ke = 23.7 nM). While the 6-substituted analogs were generally inactive, several 6-amino compounds bearing ester groups showed reasonable potency (26 a, Ke = 427 nM). Further, we show evidence that suggests several compounds initially displaying insurmountable antagonism at the OX1 receptor are competitive antagonists with slow dissociation rates.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
1,2,3,4-テトラヒドロイソキノリン, 95%
Sigma-Aldrich
N-Benzyl-2-bromoacetamide, AldrichCPR